299 related articles for article (PubMed ID: 10792482)
1. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites.
Kaufmann O; Dietel M
Histopathology; 2000 May; 36(5):415-20. PubMed ID: 10792482
[TBL] [Abstract][Full Text] [Related]
2. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors.
Agoff SN; Lamps LW; Philip AT; Amin MB; Schmidt RA; True LD; Folpe AL
Mod Pathol; 2000 Mar; 13(3):238-42. PubMed ID: 10757334
[TBL] [Abstract][Full Text] [Related]
3. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas.
Ordóñez NG
Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1.
Leech SN; Kolar AJ; Barrett PD; Sinclair SA; Leonard N
J Clin Pathol; 2001 Sep; 54(9):727-9. PubMed ID: 11533085
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor.
Byrd-Gloster AL; Khoor A; Glass LF; Messina JL; Whitsett JA; Livingston SK; Cagle PT
Hum Pathol; 2000 Jan; 31(1):58-62. PubMed ID: 10665914
[TBL] [Abstract][Full Text] [Related]
6. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.
Du EZ; Goldstraw P; Zacharias J; Tiffet O; Craig PJ; Nicholson AG; Weidner N; Yi ES
Hum Pathol; 2004 Jul; 35(7):825-31. PubMed ID: 15257545
[TBL] [Abstract][Full Text] [Related]
7. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas.
Cheuk W; Kwan MY; Suster S; Chan JK
Arch Pathol Lab Med; 2001 Feb; 125(2):228-31. PubMed ID: 11175640
[TBL] [Abstract][Full Text] [Related]
8. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B.
Kaufmann O; Dietel M
Histopathology; 2000 Jan; 36(1):8-16. PubMed ID: 10632746
[TBL] [Abstract][Full Text] [Related]
9. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.
Folpe AL; Gown AM; Lamps LW; Garcia R; Dail DH; Zarbo RJ; Schmidt RA
Mod Pathol; 1999 Jan; 12(1):5-8. PubMed ID: 9950155
[TBL] [Abstract][Full Text] [Related]
10. Thyroid transcription factor-1 is of limited value in practical distinction between pulmonary and extrapulmonary small cell carcinomas.
Cheuk W; Chan JK
Am J Surg Pathol; 2001 Apr; 25(4):545-6. PubMed ID: 11257635
[No Abstract] [Full Text] [Related]
11. SMARCA4 (BRG1) and SMARCB1 (INI1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma.
Gandhi JS; Alnoor F; Sadiq Q; Solares J; Gradowski JF
Pathol Res Pract; 2021 Mar; 219():153341. PubMed ID: 33581550
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
Srodon M; Westra WH
Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
[TBL] [Abstract][Full Text] [Related]
13. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
14. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
Zamecnik J; Kodet R
Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
[TBL] [Abstract][Full Text] [Related]
15. IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liver.
Denby KS; Briones AJ; Bourne PA; Spaulding BO; Lu D; Fischer-Colbrie R; Qu Z; Wang HL; Xu H
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):573-9. PubMed ID: 22495359
[TBL] [Abstract][Full Text] [Related]
16. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade.
Jerome Marson V; Mazieres J; Groussard O; Garcia O; Berjaud J; Dahan M; Carles P; Daste G
Histopathology; 2004 Aug; 45(2):125-34. PubMed ID: 15279630
[TBL] [Abstract][Full Text] [Related]
17. B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in merkel cell carcinoma and small cell carcinomas.
Dong HY; Liu W; Cohen P; Mahle CE; Zhang W
Am J Surg Pathol; 2005 May; 29(5):687-92. PubMed ID: 15832095
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of PAX5 and TdT by Merkel cell carcinoma and pulmonary small cell carcinoma: a potential diagnostic pitfall but useful discriminatory marker.
Kolhe R; Reid MD; Lee JR; Cohen C; Ramalingam P
Int J Clin Exp Pathol; 2013; 6(2):142-7. PubMed ID: 23329999
[TBL] [Abstract][Full Text] [Related]
19. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites.
Oliveira AM; Tazelaar HD; Myers JL; Erickson LA; Lloyd RV
Am J Surg Pathol; 2001 Jun; 25(6):815-9. PubMed ID: 11395561
[TBL] [Abstract][Full Text] [Related]
20. CD117, CK20, TTF-1, and DNA topoisomerase II-alpha antigen expression in small cell tumors.
Yang DT; Holden JA; Florell SR
J Cutan Pathol; 2004 Mar; 31(3):254-61. PubMed ID: 14984578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
